| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.952 | 0 | 0.952 | Lanosterol 14 alpha demethylase inhibitor | 0.793 0.001 DBMET00071 0.887 0.001 DBMET00072 0.375 0.002 DBMET01185 0.587 0.001 DBMET01184 0.519 0.002 DBMET01186 0.148 0.012 DBMET01187 | ||
| 0.52 | 0.003 | 0.553 | Cell wall synthesis inhibitor | 0.478 0.004 DBMET00071 0.499 0.003 DBMET00072 0.362 0.007 DBMET01185 0.553 0.002 DBMET01184 0.353 0.008 DBMET01186 0.474 0.004 DBMET01187 | DBMET01184 | |
| 0.255 | 0.01 | 0.255 | GABA receptor agonist | 0.104 0.073 DBMET00071 0.228 0.013 DBMET00072 0.203 0.017 DBMET01185 0.127 0.051 DBMET01186 | ||
| 0.247 | 0.007 | 0.247 | Aromatase inhibitor | 0.081 0.027 DBMET00071 0.187 0.009 DBMET00072 0.2 0.009 DBMET01185 0.124 0.017 DBMET01186 | ||
| 0.242 | 0.006 | 0.242 | GABA A receptor agonist | 0.09 0.048 DBMET00071 0.214 0.008 DBMET00072 0.172 0.013 DBMET01185 0.094 0.043 DBMET01186 | ||
| 0.11 | 0.034 | 0.11 | Alpha 2d adrenoreceptor antagonist | 0.1 0.048 DBMET00071 0.098 0.051 DBMET00072 | ||
| 0.083 | 0.039 | 0.129 | Sphingosine 1-phosphate receptor antagonist | 0.075 0.058 DBMET00072 0.129 0.01 DBMET01185 0.102 0.02 DBMET01186 | DBMET01185 | |
| 0.101 | 0.062 | 0.101 | Hedgehog signaling inhibitor | 0.097 0.071 DBMET00072 | ||
| 0.044 | 0.03 | 0.046 | Geranyltranstransferase inhibitor | 0.044 0.03 DBMET01185 0.046 0.028 DBMET01186 | DBMET01186 | |
| 0.141 | 0.14 | 0.339 | Anticonvulsant | 0.226 0.067 DBMET00072 0.281 0.046 DBMET01185 0.339 0.031 DBMET01186 | DBMET01186 | |
| 0.096 | 0.097 | 0.36 | M18 aspartyl aminopeptidase inhibitor | 0.278 0.016 DBMET01185 0.36 0.007 DBMET01186 0.183 0.039 DBMET01187 | DBMET01186 | |
| 0.045 | 0.051 | 0.063 | Alpha 1b adrenoreceptor agonist | 0.056 0.024 DBMET01185 0.063 0.016 DBMET01186 | DBMET01186 | |
| 0.029 | 0.041 | 0.061 | Glutamate (mGluR3) antagonist | 0.057 0.009 DBMET01185 0.061 0.008 DBMET01186 | DBMET01186 | |
| 0.03 | 0.042 | 0.054 | Glutamate (mGluR group II) antagonist | 0.054 0.014 DBMET01185 0.051 0.015 DBMET01186 | DBMET01185 | |
| 0.089 | 0.103 | 0.204 | Cholesterol synthesis inhibitor | 0.106 0.079 DBMET00072 0.109 0.076 DBMET01185 0.204 0.026 DBMET01186 0.15 0.044 DBMET01187 | DBMET01186 | |
| 0.022 | 0.04 | 0.04 | Glutamate (mGluR2) antagonist | 0.04 0.012 DBMET01185 0.036 0.014 DBMET01186 | DBMET01185 | |
| 0.007 | 0.028 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 DBMET01185 0.012 0.009 DBMET01186 | DBMET01185 | |
| 0.036 | 0.072 | 0.133 | Heme oxygenase inhibitor | 0.133 0.002 DBMET01185 0.118 0.003 DBMET01186 | DBMET01185 | |
| 0.036 | 0.074 | 0.045 | Benzodiazepine inverse agonist | 0.045 0.035 DBMET01185 | DBMET01185 | |
| 0.042 | 0.088 | 0.094 | Sphingosine 1-phosphate receptor 1 antagonist | 0.094 0.01 DBMET01185 0.086 0.012 DBMET01186 | DBMET01185 | |
| 0.039 | 0.085 | 0.06 | Thromboxane synthase inhibitor | 0.053 0.04 DBMET01185 0.06 0.028 DBMET01186 | DBMET01186 | |
| 0.051 | 0.114 | 0.143 | Exportin-1 inhibitor | 0.143 0.004 DBMET01185 0.136 0.004 DBMET01186 | DBMET01185 | |
| 0.007 | 0.073 | 0.021 | Estrone sulfatase inhibitor | 0.021 0.016 DBMET01185 | DBMET01185 | |
| 0.03 | 0.118 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.009 DBMET01185 0.065 0.011 DBMET01186 | DBMET01185 | |
| 0.031 | 0.126 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET01186 | DBMET01186 | |
| 0.033 | 0.134 | 0.078 | Glutamate receptor agonist | 0.078 0.055 DBMET01185 | DBMET01185 | |
| 0.09 | 0.194 | 0.166 | Sphingosine 1-phosphate receptor 2 antagonist | 0.166 0.024 DBMET01185 0.145 0.048 DBMET01186 | DBMET01185 | |
| 0.015 | 0.128 | 0.076 | Alpha 1d adrenoreceptor agonist | 0.05 0.016 DBMET01185 0.076 0.006 DBMET01186 | DBMET01186 | |
| 0.009 | 0.125 | 0.051 | Alpha 1a adrenoreceptor agonist | 0.051 0.005 DBMET01186 | DBMET01186 | |
| 0.049 | 0.177 | 0.172 | DNA intercalator | 0.172 0.034 DBMET01185 0.089 0.087 DBMET01184 0.144 0.045 DBMET01187 | DBMET01185 | |
| 0.057 | 0.189 | 0.104 | Beta amyloid protein antagonist | 0.104 0.085 DBMET01184 | DBMET01184 | |
| 0.04 | 0.172 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.044 DBMET01185 0.07 0.058 DBMET01186 | DBMET01185 | |
| 0.034 | 0.171 | 0.074 | Aryl hydrocarbon receptor antagonist | 0.074 0.033 DBMET01185 | DBMET01185 | |
| 0.033 | 0.218 | 0.1 | HIV-1 integrase inhibitor | 0.1 0.024 DBMET01185 0.07 0.048 DBMET01186 | DBMET01185 | |
| 0.014 | 0.218 | 0.054 | Plasminogen activator inhibitor | 0.054 0.044 DBMET01186 | DBMET01186 | |
| 0.019 | 0.224 | 0.201 | NMDA 2B receptor antagonist | 0.201 0.005 DBMET01186 | DBMET01186 | |
| 0.018 | 0.224 | 0.08 | MAP kinase 14 inhibitor | 0.08 0.046 DBMET01185 | DBMET01185 | |
| 0.012 | 0.219 | 0.044 | Protein kinase (CK1) epsilon inhibitor | 0.044 0.019 DBMET01185 | DBMET01185 | |
| 0.084 | 0.292 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.155 0.053 DBMET01185 0.137 0.085 DBMET01186 | DBMET01185 | |
| 0.019 | 0.243 | 0.089 | Dipeptidyl peptidase IV inhibitor | 0.089 0.006 DBMET01185 | DBMET01185 | |
| 0.014 | 0.268 | 0.071 | Acetyl-CoA transferase inhibitor | 0.071 0.024 DBMET01185 | DBMET01185 | |
| 0.085 | 0.34 | 0.153 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.153 0.128 DBMET01186 | DBMET01186 | |
| 0.113 | 0.368 | 0.264 | Nitric-oxide synthase stimulant | 0.242 0.038 DBMET01185 0.264 0.024 DBMET01186 0.226 0.053 DBMET01187 | DBMET01186 | |
| 0.03 | 0.297 | 0.103 | Creatine kinase inhibitor | 0.101 0.058 DBMET01185 0.103 0.056 DBMET01186 | DBMET01186 | |
| 0.046 | 0.328 | 0.134 | Glutamate (mGluR7) agonist | 0.134 0.019 DBMET01185 0.127 0.024 DBMET01186 | DBMET01185 | |
| 0.06 | 0.347 | 0.199 | NOS3 expression enhancer | 0.18 0.05 DBMET01184 0.199 0.041 DBMET01187 | DBMET01187 | |
| 0.048 | 0.344 | 0.169 | Heat shock protein 90 alpha antagonist | 0.169 0.07 DBMET01185 | DBMET01185 | |
| 0.005 | 0.311 | 0.056 | Potassium channel (Inward rectifier) 1 blocker | 0.056 0.004 DBMET01186 0.03 0.022 DBMET01187 | DBMET01186 | |
| 0.017 | 0.324 | 0.085 | Dipeptidyl peptidase inhibitor | 0.085 0.012 DBMET01185 | DBMET01185 | |
| 0.004 | 0.344 | 0.082 | Oleamide hydrolase inhibitor | 0.082 0.012 DBMET01185 0.059 0.021 DBMET01186 | DBMET01185 | |
| 0.025 | 0.371 | 0.235 | Ferrochelatase inhibitor | 0.114 0.058 DBMET01185 0.235 0.015 DBMET01186 | DBMET01186 | |
| 0.04 | 0.386 | 0.248 | Potassium channel blocker | 0.248 0.067 DBMET01186 | DBMET01186 | |
| 0.03 | 0.408 | 0.055 | Lipocortins synthesis agonist | 0.055 0.047 DBMET01187 | DBMET01187 | |
| 0.008 | 0.392 | 0.059 | Chemokine receptor agonist | 0.059 0.028 DBMET00071 | DBMET00071 | |
| 0.086 | 0.479 | 0.129 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 DBMET01186 | DBMET01186 | |
| 0.028 | 0.43 | 0.122 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.122 0.038 DBMET01185 0.082 0.078 DBMET01186 | DBMET01185 | |
| 0.007 | 0.414 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DBMET01186 | DBMET01186 | |
| 0.001 | 0.424 | 0.017 | Protease activated receptor 1 agonist | 0.017 0.005 DBMET01185 | DBMET01185 | |
| 0.015 | 0.449 | 0.095 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.095 0.012 DBMET01185 | DBMET01185 | |
| 0.025 | 0.466 | 0.094 | Triose-phosphate isomerase inhibitor | 0.094 0.054 DBMET01187 | DBMET01187 | |
| 0.004 | 0.454 | 0.052 | Protease activated receptor 1 antagonist | 0.052 0.031 DBMET01185 | DBMET01185 | |
| 0.027 | 0.481 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 DBMET01187 | DBMET01187 | |
| 0.004 | 0.461 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 DBMET01187 | DBMET01187 | |
| 0.053 | 0.517 | 0.217 | Cholesterol antagonist | 0.217 0.15 DBMET01187 | DBMET01187 | |
| 0.003 | 0.474 | 0.058 | Sodium/glucose cotransporter 2 inhibitor | 0.058 0.005 DBMET01187 | DBMET01187 | |
| 0.034 | 0.508 | 0.289 | Nitric oxide antagonist | 0.208 0.064 DBMET01184 0.289 0.043 DBMET01187 | DBMET01187 | |
| 0.007 | 0.481 | 0.064 | Amidase inhibitor | 0.064 0.059 DBMET01185 | DBMET01185 | |
| 0.006 | 0.483 | 0.071 | Alpha adrenoreceptor agonist | 0.071 0.045 DBMET01186 | DBMET01186 | |
| 0.117 | 0.601 | 0.299 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.299 0.214 DBMET01185 | DBMET01185 | |
| 0.004 | 0.489 | 0.05 | Sodium/glucose cotransporter inhibitor | 0.05 0.005 DBMET01187 | DBMET01187 | |
| 0.012 | 0.502 | 0.109 | Glutamate receptor antagonist | 0.109 0.087 DBMET01186 | DBMET01186 | |
| 0.027 | 0.518 | 0.136 | Toll-Like receptor 4 antagonist | 0.135 0.03 DBMET01184 0.136 0.03 DBMET01187 | DBMET01187 | |
| 0.008 | 0.502 | 0.051 | Potassium channel (Inward rectifier) blocker | 0.051 0.033 DBMET01186 | DBMET01186 | |
| 0.005 | 0.518 | 0.061 | Protease activated receptor antagonist | 0.061 0.046 DBMET01185 | DBMET01185 | |
| 0.006 | 0.522 | 0.051 | Alpha 1 adrenoreceptor agonist | 0.051 0.05 DBMET01186 | DBMET01186 | |
| 0.026 | 0.571 | 0.253 | DNA synthesis inhibitor | 0.253 0.064 DBMET01187 | DBMET01187 | |
| 0.008 | 0.559 | 0.082 | Neuraminidase (influenza) inhibitor | 0.082 0.024 DBMET01187 | DBMET01187 | |
| 0.075 | 0.627 | 0.376 | Interleukin 2 agonist | 0.376 0.035 DBMET01184 0.369 0.038 DBMET01187 | DBMET01184 | |
| 0.056 | 0.613 | 0.246 | GABA C receptor rho-3 antagonist | 0.246 0.158 DBMET01185 | DBMET01185 | |
| 0.034 | 0.59 | 0.166 | Interferon gamma antagonist | 0.166 0.06 DBMET01187 | DBMET01187 | |
| 0.022 | 0.592 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.089 DBMET01185 | DBMET01185 | |
| 0.031 | 0.604 | 0.224 | Interleukin agonist | 0.186 0.134 DBMET01186 0.224 0.099 DBMET01187 | DBMET01187 | |
| 0.034 | 0.609 | 0.374 | Immunosuppressant | 0.358 0.083 DBMET01184 0.374 0.074 DBMET01187 | DBMET01187 | |
| 0.007 | 0.585 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET01187 | DBMET01187 | |
| 0.022 | 0.608 | 0.284 | Amylase inhibitor | 0.102 0.095 DBMET01185 0.284 0.02 DBMET01187 | DBMET01187 | |
| 0.01 | 0.597 | 0.117 | Topoisomerase I inhibitor | 0.117 0.058 DBMET01187 | DBMET01187 | |
| 0.013 | 0.603 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.103 0.057 DBMET01187 | DBMET01187 | |
| 0.015 | 0.617 | 0.177 | Hypolipemic | 0.177 0.112 DBMET01187 | DBMET01187 | |
| 0.028 | 0.631 | 0.1 | Transcription factor NF kappa B stimulant | 0.085 0.06 DBMET01184 0.1 0.038 DBMET01187 | DBMET01187 | |
| 0.075 | 0.684 | 0.2 | 5 Hydroxytryptamine uptake stimulant | 0.2 0.151 DBMET01185 | DBMET01185 | |
| 0.014 | 0.632 | 0.074 | Factor IXa inhibitor | 0.074 0.018 DBMET01187 | DBMET01187 | |
| 0.037 | 0.664 | 0.265 | Immunomodulator | 0.265 0.104 DBMET01184 0.218 0.144 DBMET01187 | DBMET01184 | |
| 0.005 | 0.634 | 0.055 | Mannosidase inhibitor | 0.055 0.02 DBMET01187 | DBMET01187 | |
| 0.005 | 0.646 | 0.097 | Adrenaline agonist | 0.097 0.039 DBMET01186 | DBMET01186 | |
| 0.008 | 0.653 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.055 0.035 DBMET01184 0.078 0.02 DBMET01187 | DBMET01187 | |
| 0.012 | 0.659 | 0.156 | Beta glucuronidase inhibitor | 0.095 0.078 DBMET01185 0.156 0.022 DBMET01187 | DBMET01187 | |
| 0.021 | 0.671 | 0.145 | Melanin inhibitor | 0.145 0.089 DBMET01187 | DBMET01187 | |
| 0.046 | 0.7 | 0.624 | Antiinflammatory | 0.467 0.102 DBMET01184 0.624 0.047 DBMET01187 | DBMET01187 | |
| 0.004 | 0.667 | 0.065 | Neuraminidase inhibitor | 0.065 0.038 DBMET01187 | DBMET01187 | |
| 0.019 | 0.695 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 DBMET01187 | DBMET01187 | |
| 0.004 | 0.692 | 0.092 | Antineoplastic antibiotic | 0.092 0.05 DBMET01187 | DBMET01187 | |
| 0.013 | 0.705 | 0.487 | Angiogenesis stimulant | 0.406 0.021 DBMET01184 0.487 0.013 DBMET01187 | DBMET01187 | |
| 0.006 | 0.708 | 0.087 | Expectorant | 0.087 0.085 DBMET01187 | DBMET01187 | |
| 0.014 | 0.727 | 0.244 | Hemostatic | 0.244 0.023 DBMET01187 | DBMET01187 | |
| 0.062 | 0.778 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.065 DBMET01187 | DBMET01187 | |
| 0.005 | 0.743 | 0.061 | Heparanase inhibitor | 0.061 0.022 DBMET01187 | DBMET01187 | |
| 0.01 | 0.749 | 0.088 | ATPase (Vacuolar H+) inhibitor | 0.088 0.059 DBMET01187 | DBMET01187 | |
| 0.03 | 0.782 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.288 0.179 DBMET01187 | DBMET01187 | |
| 0.008 | 0.763 | 0.148 | AMP-activated protein kinase stimulant | 0.148 0.029 DBMET01187 | DBMET01187 | |
| 0.012 | 0.774 | 0.136 | Insulin secretagoues | 0.136 0.09 DBMET01187 | DBMET01187 | |
| 0.02 | 0.787 | 0.23 | Vasodilator, coronary | 0.23 0.154 DBMET01187 | DBMET01187 | |
| 0.014 | 0.787 | 0.333 | Antiobesity | 0.305 0.113 DBMET01186 0.333 0.096 DBMET01187 | DBMET01187 | |
| 0.02 | 0.797 | 0.509 | Hypoglycemic | 0.263 0.069 DBMET01184 0.509 0.014 DBMET01187 | DBMET01187 | |
| 0.008 | 0.788 | 0.062 | Antibiotic Aminoglycoside-like | 0.044 0.017 DBMET01184 0.062 0.008 DBMET01187 | DBMET01187 | |
| 0.01 | 0.801 | 0.661 | Antibacterial | 0.418 0.069 DBMET01184 0.316 0.124 DBMET01186 0.661 0.012 DBMET01187 | DBMET01187 | |
| 0.018 | 0.825 | 0.127 | DNA repair enzyme inhibitor | 0.127 0.06 DBMET01187 | DBMET01187 | |
| 0.005 | 0.813 | 0.086 | Adrenaline antagonist | 0.086 0.063 DBMET01186 | DBMET01186 | |
| 0.008 | 0.819 | 0.178 | Thrombolytic | 0.178 0.063 DBMET01187 | DBMET01187 | |
| 0.005 | 0.816 | 0.089 | Antiadrenergic | 0.089 0.063 DBMET01186 | DBMET01186 | |
| 0.008 | 0.822 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET01187 | DBMET01187 | |
| 0.005 | 0.846 | 0.202 | Platelet antagonist | 0.202 0.099 DBMET01187 | DBMET01187 | |
| 0.011 | 0.857 | 0.73 | Cyclophilin D inhibitor | 0.486 0.055 DBMET01184 0.314 0.15 DBMET01186 0.73 0.011 DBMET01187 | DBMET01187 | |
| 0.007 | 0.853 | 0.304 | Antithrombotic | 0.304 0.085 DBMET01187 | DBMET01187 | |
| 0.018 | 0.865 | 0.297 | Hepatoprotectant | 0.217 0.056 DBMET01184 0.297 0.03 DBMET01187 | DBMET01187 | |
| 0.004 | 0.852 | 0.296 | Selectin antagonist | 0.207 0.01 DBMET01184 0.296 0.005 DBMET01187 | DBMET01187 | |
| 0.048 | 0.919 | 0.352 | Peptidyltransferase inhibitor | 0.25 0.05 DBMET01184 0.352 0.012 DBMET01187 | DBMET01187 | |
| 0.005 | 0.878 | 0.229 | Transcription factor NF kappa B inhibitor | 0.229 0.143 DBMET01187 | DBMET01187 | |
| 0.051 | 0.926 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET01186 | DBMET01186 | |
| 0.005 | 0.881 | 0.122 | Bronchodilator | 0.122 0.044 DBMET01186 | DBMET01186 | |
| 0.003 | 0.891 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET01187 | DBMET01187 | |
| 0.017 | 0.916 | 0.251 | Apoptosis antagonist | 0.205 0.173 DBMET01184 0.251 0.127 DBMET01187 | DBMET01187 | |
| 0.005 | 0.915 | 0.384 | Antioxidant | 0.221 0.101 DBMET01184 0.384 0.038 DBMET01187 | DBMET01187 | |
| 0.004 | 0.923 | 0.185 | Immunostimulant | 0.185 0.13 DBMET01187 | DBMET01187 | |
| 0.004 | 0.931 | 0.186 | Thioredoxin glutathione reductase inhibitor | 0.186 0.185 DBMET01185 | DBMET01185 | |
| 0.004 | 0.931 | 0.095 | Topoisomerase II inhibitor | 0.095 0.091 DBMET01187 | DBMET01187 | |
| 0.005 | 0.937 | 0.176 | Tumour necrosis factor alpha release inhibitor | 0.176 0.129 DBMET01187 | DBMET01187 | |
| 0.007 | 0.945 | 0.203 | Platelet adhesion inhibitor | 0.203 0.07 DBMET01187 | DBMET01187 | |
| 0.004 | 0.951 | 0.122 | Lipid peroxidase inhibitor | 0.122 0.091 DBMET01187 | DBMET01187 | |
| 0.004 | 0.964 | 0.351 | Free radical scavenger | 0.164 0.13 DBMET01184 0.351 0.038 DBMET01187 | DBMET01187 | |
| 0.004 | 0.981 | 0.125 | Anticoagulant | 0.125 0.106 DBMET01187 | DBMET01187 | |
| 0.005 | 0.991 | 0.295 | Apoptosis agonist | 0.295 0.175 DBMET01187 | DBMET01187 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |